SCHEMBL3762282

SCHEMBL3762282

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3cc(N)nc(-c4ccccc4)c3)c2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 10/20 0.41
PIK3CD O00329 6/20 0.41
PIK3CB P42338 5/20 0.41
PIK3CG P48736 5/20 0.41
BRD4 O60885 1/20 0.38
HSD17B10 Q99714 3/20 0.38
PIK3C3 Q8NEB9 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
MAPK1 P28482 2/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
BUB1 O43683 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 2/20 0.37
ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764482 0.85 BUB1 (0.44) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3760142 0.84 PIK3CA (0.45) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3758948 0.83 PIK3CD (0.42) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3757825 0.83 MTOR (0.38) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3759885 0.83 MTOR (0.38) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3759076 0.83 PIK3CD (0.41) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3757385 0.83 BRD4 (0.41) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3764864 0.82 PIK3CA (0.42) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3754664 0.81 GABRA1 (0.42) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3760082 0.80 HRH1 (0.46) PIK3CAPIK3CBHSD17B10LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885PIK3CD 9/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.